Table 1.
Patient characteristics: stage and ECOG performance status at baseline.
| 65–69 Years n = 91 | 70–74 Years n = 79 | 75–79 Years n = 53 | >80 Years n = 57 | Total n = 280 | p | |
|---|---|---|---|---|---|---|
| n (%) | n (%) | n (%) | n (%) | n (%) | ||
| FIGO Stage | ||||||
| 1 | 13 (14.3) | 4 (5.1) | 8 (15.1) | 12 (21.1) | 37 (13.2) | 0.293 |
| 2 | 9 (9.9) | 10 (12.7) | 3 (5.7) | 3 (5.3) | 28 (10.0) | |
| 3 | 52 (57.1) | 44 (55.7) | 33 (62.3) | 29 (50.9) | 158 (56.4) | |
| 4 | 16 (17.6) | 21 (26.6) | 6 (11.3) | 12 (21.1) | 55 (19.6) | |
| Unknown | 1 (1.1) | 0 | 0 | 1 (1.8) | 2 (0.7) | |
| ECOG PS | ||||||
| 0 | 30 (33.0) | 12 (15.2) | 9 (17.0) | 5 (8.8) | 56 (20.0) | 0.008 |
| 1 | 34 (37.4) | 38 (48.1) | 27 (50.9) | 23 (40.4) | 122 (43.6) | |
| 2 | 14 (15.4) | 18 (22.8) | 8 (15.1) | 15 (26.3) | 55 (19.6) | |
| 3 | 5 (5.5) | 9 (11.4) | 3 (5.7) | 9 (15.8) | 26 (9.3) | |
| Unknown | 8 (8.8) | 2 (2.5) | 6 (11.3) | 5 (8.8) | 21 (7.5) | |
| Histological subtype | ||||||
| High grade serous | 62 (68.1) | 57 (72.2) | 36 (67.9) | 40 (70.2) | 195 (69.6) | 0.547 |
| Low grade serous | 3 (3.3) | 3 (3.8) | 3 (5.7) | 3 (5.3) | 12 (4.3) | |
| Carcinosarcoma | 6 (6.6) | 5 (6.3) | 4 (7.5) | 6 (10.5) | 21 (7.5) | |
| Clear cell | 8 (8.8) | 1 (1.3) | 2 (3.8) | 1 (1.8) | 12 (4.3) | |
| Endometrioid | 7 (7.7) | 3 (3.8) | 2 (3.8) | 2 (3.5) | 14 (5.0) | |
| Mucinous | 1 (1.1) | 2 (2.5) | 0 | 0 | 3 (1.1) | |
| Adenocarcinoma/Mixed/ Undifferentiated | 4 (4.4) | 8 (10.1) | 6 (11.3) | 5 (8.8) | 23 (8.2) | |